Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No longer just a speculative buy based on potential

No longer just a speculative buy based on potential

posted on Jan 16, 2008 12:56PM

Part of our SP fall may be a function of the maturing of PTSC. The market has now seen 6 or more quarters of real income, most with positive EPS. That's not a bad record.

The point is PTSC has TTM earnigs to help set its SP value. PTSC's future potential is tied to tech stocks buying licenses. The NASDAQ has been hit hard. Technology companies have been falling fast (Intel down over 12% just today). PTSC is dependent on Tech Companies for it's revenue. Companies when stretched for income often delay expenditures. Expenditures would include multimillion dollar patent licenses.

A mature company is not just valued on potential. Market factors begin to play a roll. Could this be a significant part of the cause of the PTSC SP fall?

 

Share
New Message
Please login to post a reply